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STEREOSPECIFIC OPIATE BINDING IN
HUMAN ERYTHROCYTE MEMBRANES AND
CHANGES IN HEROIN ADDICTS
Leo G. Abood, Holly G. Atkinson, and Mary MacNeil
Center for Brain Research and Department o f Biochemistry, University of
Rochester Medical Center, Rochester, New York

Stereospecific opiate binding has been demonstrated in human erythrocyte membranes, having a Kd of 9 lo-’ M. In most respects the binding characteristics
resemble those of snyaptic membranes. These included the correlation of binding
affinity and pharmacological potency of opiates; competition by naloxone; inhibition by Ca2+ and Na’; and sensitivity to phospholipases and trypsin. A comparison of stereospecific opiate binding in control human subjects and heroin
addicts revealed a 43% increase in the addict group.
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In recent years, there has been considerable interest in the identification of the
“opiate receptor” in brain tissue, and in the attempt to correlate the binding affinity of
opiates to their pharmacological action (Goldstein et al., 1971; Pert and Snyder, 1973;
Simon et al., 1973). Our interest in opiate binding developed from the observation that
phosphatidyl serine not only exhibited stereospecific binding for opiates (Abood and
Hoss, 197.9, but its addition to neural membrane preparations significantly enhanced
stereospecific binding (Abood and Takeda, 1976). Since erythrocyte membranes contain
a significant amount of phosphatidyl serine (Pasternak and Snyder, 1974), while the total
lipid extract exhibits opiate binding, a study was undertaken to determine whether high
affinity opiate binding occurred in the membranes. Initial attempts to demonstrate stereospecific opiate binding to intact erythrocytes were unsuccessful, largely due to the fact
that the hemoglobin, which leaked out into the incubation medium, was inhibitory to
binding. The present study established that human erythrocyte membranes exhibit high
affinity stereospecific binding for opiates, and that the binding site has many characteristics of the sites present in the brain tissue. In addition, a comparison was made of opiate
binding in erythrocyte membranes of control subjects and heroin addicts.

Address reprint requests to Leo G. Abood, Ph.D., Center for Brain Research, Box 605,
University of Rochester Medical Center, Rochester, NY 14642.
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Freshly drawn heparinized human blood was diluted with 5 volumes of 10 mM icecold Tris-EDTA, pH 7.5, and after 30 min was centrifuged at 100,000 g for 30 min. The
pellet was homogenized in five times the original blood volume of 10 mM Tris-EDTA and
recentrifuged. The washing procedure was repeated four times or until the hemoglobin had
been removed. Stereospecific opiate binding was measured by the technique of Pert and
Snyder (1973). A typical incubation medium contained the following in a final volume of
1.2 ml: 0.05 M Tris, pH 7.5,0.05 pC of H-dihydromorphine (3 H-DHM), specific activity
71 curies/mmole, and either
M levorphanol or dextrorphan. After 15-min incubation at 35"C, the samples were filtered by suction through a Whatman GF/B glass fiber
filter, which was washed twice with 5 ml of ice-cold Tris buffer and transferred to a liquid
scintillation vial for measuring radioactivity. All of the addicts used in the study were
presently on heroin and had been on the drug for at least 1 year. The group consisted of
seven males and three females ranging in age from 21 to 35 years.
In an effort to compare the opiate binding characteristics of erythrocyte membranes
t o those of brain tissue, the effect of a number of parameters known to influence the
latter were examined (Table I). All values were expressed in terms of specific binding,
which represented the difference in counts/min of the bound H-DHM in the presence of
lop7 M dextrorphan from that in the presence of the experimental agent. At a concentration of 10-7 M hydromorphone produced complete inhibition and morphine 85%,

TABLE I. Effect of Various Treatments o n Binding of 3H-DHM t o Erythrocyte
Membranes
3H-DHM
bound

Dextorphan
Levorphanol
Hydromorphone
Morphine
Codeine
Naloxone
M CaClz
0.05 M NaCl
Philpase A
Philpase C
Trypsin
P-Serine

845
602
586
638
7 86
713
590
580
6 10
603
552
7 05

Specific
binding,
CPm

Specific binding*

5% change

'%brain change

-

-

-

243
259
207
59
45
255
265
235
242
293
140

-106
- 85
- 25
- 18
-104
-109
- 97
- 100
-120
- 58

-

-100
90
- 45
- 95
- 95
-100
- 90
- 50
-100
+3 5
-

Membranes were exposed t o various treatments or drugs 30 min prior t o the addition
of 3H-DHM. Incubation medium described in text; each tube containing 1.3 mg membrane protein. Amounts of phospholipase A (bee venom), phospholipase C (B. cereus)
and trypsin (crystalline, treated with diphenyl carbamyl choline) was 1 unit, 2 units,
and 0.2 mg respectively. Phosphatidyl serine was 99% pure (bovine brain) and used at
a concentration of 100 p/mg protein. See (5) for details on use of enzymes and phosphatidyl serine.
*Specific binding: (243-column 2 ) . 1 0 0 .
243
The values represent the mean of three separate experiments run in triplicate, and the
variation from the mean was less than 6%.
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values comparable to those obtained with rat brain synaptic membranes. Codeine, a weaker
opiate, produced a 35% inhibition in erythrocytes as compared with 45% in the brain. On
the other hand, the opiate antagonist naloxone had only a small effect on erythrocytes at
M) and NaCl (0.05 M)
a concentration completely inhibitory to brain. Both CaClz
produced complete inhibition in both preparations, as did exposure to phospholipase A
and trypsin. The erythrocyte appeared to be more sensitive to treatment with phospholipase C. Upon the addition of phosphatidyl serine (100 pg/mg membrane protein), binding
was inhibited 58% as compared to a 35% enhancement of synaptic membranes.
A Scatchard analysis was performed on the stereospecific opiate binding of erythrocyte membranes from control human blood (Fig. 1). The Kd was calculated t o be 9
M. This value compares with the lower affinity binding of brain tissue which exhibits a biphasic Scatchard plot with K d s of 5 lo-'' M and 8
M (Abood and
Takeda, 1976; Pasternak and Snyder, 1975).
A preliminary study was performed on the stereospecific binding of erythrocytes obtained from a group of ten heroin addicts and an equal number of control subjects (Table
11). The mean value of the control group was 130 k 25, with the range being 115-180.
This compares with a mean of 202 k 38 in the addicts, with a range of 160-225. The mean
is 43% greater in the addict than in the control group, the difference being significant at
P < 0.01 (t test). It should be emphasized that the population of both control subjects
and heroin addicts is too small to conclude that opiate binding increases during drug addiction; however, the data do encourage a more extensive study.

-

-

10

-

20

bound DHM moles

~10''

Fig. 1. Scatchard plot of 3Hdihydromorphine binding to human erythrocyte membranes. All assays
were run in triplicate and represent two separate experiments. Binding is stereospecific, representing
the difference in the presence of lo-' M levorphanol and dextorphan. Each tube contained 1 mg
membrane protein in 0.05 M Tris, pH 7.5, and varying concentrations of 3Hdihydromorphine. The
points are an average of three separate experiments run in triplicate; the variation from the mean being
no more than 6%.
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TABLE 11. Stereospecific Opiate Binding in Erythrocyte Membranes of
Control Human Subjects and Heroin Addicts

Controls
Addicts

No. of
subjects

3H-DHM
binding

10
10

CPm
130 h 25
202f38

Range

115-180
160-225

%
Increase

-

43*

Stereospecific binding was expressed as difference in cpm of bound
M dextrorphan from that in the
3H-DHM in the presence of
presence of l o r 7 M levorphanol. Values are expressed as mean ?
standard deviation counts/min/mg protein
*Significant at P <O.Ol

(t test).

The significance of the present study in terms of the pharmacological action of
opiates is difficult to assess. It is, however, apparent that the characteristics of the opiate
binding in erythrocyte membranes are very similar to those of brain tissue. Opiate binding in both tissues is inhibited by phospholipase A or C as well as by trypsin and NaCl .
The opiate antagonist naloxone is antagonistic t o H-DHM binding in both preparations;
however, the erythrocyte is only one-fifth as sensitive as synaptic membranes. Both Ca2+ and
Na' are completely inhibitory to both types of membranes. There appears to be a relationship between the affinity of various opiates and their pharmacological potency, hydromorphone being the most potent opiate and codeine the least. A major difference was the
effect of added phosphatidyl serine w h c h significantly enhanced opiate binding in brain
tissue but was actually inhibitory to that in erythrocytes. Erythrocytes already contain a
comparatively large proportion of phosphatidyl serine, as much as 20% of the total phospholipid (Rouser et al., 1968); consequently, all binding sites evidently have their complement of this lipid. As discussed elsewhere (Abood and Takeda, 1976; Abood et al., in
press), stereospecific opiate binding in neural membranes is significantly enhanced by
phosphatidyl serine, a finding which suggests that phosphatidyl serine may be a component of the binding site.
Although the observed increase in opiate binding in the erythrocyte membranes of
heroin addicts is based on only a few subjects, chronic drug usage is generally associated
with a variety of adaptive mechanisms. The observation is also in conformity with the
report that chronic administration of opiates to rats increases the number of opiate binding sites in the brain (Pert and Snyder, 1976).
A major difference was the inability of naloxone to compete for the erythrocyte
binding site. At present the only plausible explanation for this difference is that the
presence of the N-ally1 substituent on the opiate molecule tends to interfere with binding
to the erythrocyte membrane. This conclusion is supported by the finding that N-allylmorphine and levalorphan, which are also morphine antagonists, at concentrations of
M do not interfere with H-DHM binding. It would appear that the reversal of
opiate binding by antagonists, which is so characteristic of the brain receptor, is absent
from erythrocytes.
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